BIPOLAR II DISORDER
Clinical trials for BIPOLAR II DISORDER explained in plain language.
Never miss a new study
Get alerted when new BIPOLAR II DISORDER trials appear
Sign up with your email to follow new studies for BIPOLAR II DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to better treat bipolar disorder in teens
Disease control Recruiting nowThis study follows 80 youth aged 9-19 with bipolar disorder to understand what affects their symptoms over a year. Participants receive medication management and talk therapy, and complete interviews and questionnaires. The goal is to improve diagnosis and treatment for young peo…
Matched conditions: BIPOLAR II DISORDER
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated May 17, 2026 02:57 UTC
-
New study matches Weight-Loss drugs to bipolar Patients' unique biology
Disease control Recruiting nowThis study tests whether matching weight-loss medications to a person's specific obesity type (like 'hungry brain' or 'emotional hunger') helps people with bipolar disorder lose weight safely. About 100 adults aged 18-65 will take one of three FDA-approved drugs or join a weight-…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 02:57 UTC
-
Head-to-Head: lithium vs lamotrigine for bipolar II mood control
Disease control Recruiting nowThis study compares lithium and lamotrigine to see which better stabilizes mood in people with bipolar II disorder. Two hundred adults aged 18-70 will be randomly assigned to one of the two drugs and track their daily mood using a phone app for six months. The goal is to find whi…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE4 • Sponsor: University Hospital Bispebjerg and Frederiksberg • Aim: Disease control
Last updated May 17, 2026 02:53 UTC
-
New pill could lift bipolar depression in weeks
Symptom relief Recruiting nowThis study tests an experimental drug called azetukalner to see if it can safely reduce depression in people with bipolar I or II disorder. About 400 adults currently in a depressive episode will receive either the drug or a placebo for 6 weeks. The main goal is to measure change…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Symptom relief
Last updated May 17, 2026 02:53 UTC
-
New pill could lift bipolar depression in just 6 weeks
Symptom relief Recruiting nowThis study tests an experimental drug called icalcaprant for treating depression in people with bipolar I or II disorder. About 195 adults will take either the drug or a placebo daily for 6 weeks. Researchers will measure mood changes using a standard depression scale and track a…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
Memory aid could unlock hidden mental health history
Knowledge-focused Recruiting nowThis study tests whether using a life history calendar—a simple grid that helps people recall important life events—can improve how accurately adults in Hong Kong remember and report past mental health problems. Researchers will compare the standard interview method with the cale…
Matched conditions: BIPOLAR II DISORDER
Sponsor: The University of Hong Kong • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC